call for abstracts
Melanoma Bridge Presidents are glad to invite the submission of abstracts for the presentation of oral communications and poster. The themes are:
- MOLECULAR AND IMMUNO ADVANCES;
- COMBINATION THERAPIES;
- NEWS IN IMMUNOTHERAPY;
- TUMOR MICROENVIRONMENT AND BIOMARKERS;
All the abstracts submitted will be reviewed by the members of the Scientific Board. The accepted abstract which have not been published elsewhere will be included in a dedicated Supplement of the Journal of Translational Medicine. The speaker of each abstract selected for oral presentation will be exempt from registration fee and the organizing committee will cover lodging for 3 nights (Dec 1st-4th) and travel expenses (in coach) to Naples.
Important Dates for Abstracts Submissions:
Submission opens: June 1st, 2015
New Submission Deadline: October 9th, 2015
Notification: October 30th, 2015
Submit your abstract as word file by e-mail to email@example.com
Receipt of your abstract will be acknowledged by e-mail within a few days. If acknowledgement is not received within one week of submission, please contact us again.
The title should be in bold, sentence case with no full stop at the end and no underlining
First name, middle initials if required, and surname with no full stop at the end. Underline the name of the corresponding author. A comma should separate author names. Where authors are from different institutions, the appropriate institution number from the affiliation list should be given as a superscript number immediately after each author's name..
Affiliations should include department, institute, town and country. Where there are multiple affiliations, each should be listed as a separate paragraph. Each institute should appear in the order used against the author names (see above paragraph) and show the appropriate superscript number.
• Should not be more than 400 words
• Please use single line spacing
• Type the text unjustified, without hyphenating words at line breaks
• Structure the abstracts with paragraph headings typed in bold with no colon at the end
- Materials and methods
The Journal of Translational Medicine supports prospective registration of randomized controlled clinical trials. Abstracts related to RCTs should include the trial registry along with the unique identifying number. Trial registers that currently meet our requirements can be found at http://www.icmje.org/about-icmje/faqs/.
All references should be cited/called out consecutively in the text, using numbers in square brackets. Only papers that have been published, or are in press, or are available through public e-print/preprint servers should be included in the reference list.
Journal abbreviations should follow MEDLINE standards.
References should be laid out at the end of the abstract and preceded by the relevant reference number. An example of a reference for a journal article follows. The full reference style guide can be found at the journal’s website.
For information please contact firstname.lastname@example.org